Related Experiment Videos
2-chlorodeoxyadenosine (2-CdA) does not change the expression of Fas antigen on chronic lymphocytic leukaemia cells
J Gora-Tybor1, E Lech-Miranda, J Z Blonski
1Department of Hematology, University of Lodz, Poland.
Advances in Experimental Medicine and Biology
|January 11, 2002
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Phase IIa study of the CD19 antibody MOR208 in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
JAK inhibitors: pharmacology and clinical activity in chronic myeloprolipherative neoplasms.
Current medicinal chemistry·2013
A targeted therapy for protein and lipid kinases in chronic lymphocytic leukemia.
Current medicinal chemistry·2012
Emerging therapies in chronic myeloid leukemia.
Current cancer drug targets·2012
The Emergent Architecture of Autonomous Clocks Described by Computational Algorithms of Regulatory Networks.
Advances in experimental medicine and biology·2026
Physical Frameworks and Theories on How Autonomous Biological Oscillators Synchronize.
Advances in experimental medicine and biology·2026
Leveraging Autonomous Biological Oscillators for Directed Evolution of Switchable Proteins.
Advances in experimental medicine and biology·2026
Synthetic Cell-Based Approaches to Dissect Autonomous Cellular Oscillators: Recent Applications on the Cell Cycle.
Advances in experimental medicine and biology·2026
Autonomous Oscillations of NF-κB.
Advances in experimental medicine and biology·2026
An Autonomous Clock that Controls Genetic Information Flow and Cellular Proteostasis.
Advances in experimental medicine and biology·2026
Correction: Feroz et al. Non-Muscle Myosin II A: Friend or Foe in Cancer? Int. J. Mol. Sci. 2024, 25, 9435.
International journal of molecular sciences·2026